← Back to headlines
Investigation Reveals Global Disparities in Access to Merck's Keytruda
A joint investigation by DW and ICIJ highlights how pricing and patent strategies have made Merck's Keytruda a top-selling drug while limiting access for many patients worldwide. The report uncovers a significant global divide in the availability of the life-saving medicine.
13 Apr, 05:13 — 13 Apr, 05:13
